• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向HIV-1四级表位的构象保真度:最小化V1V2抗原的计算设计与定向进化

Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen.

作者信息

Lai Jennifer I, Verma Deeptak, Bailey-Kellogg Chris, Ackerman Margaret E

机构信息

Thayer School of Engineering, Dartmouth College, 14 Engineering Dr, Hanover NH, USA.

Department of Computer Science, Dartmouth College, 9 Maynard St, Hanover NH, USA.

出版信息

Protein Eng Des Sel. 2018 Apr 1;31(4):121-133. doi: 10.1093/protein/gzy010.

DOI:10.1093/protein/gzy010
PMID:29897567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6030936/
Abstract

Structure-based approaches to antigen design utilize insights from antibody (Ab):antigen interactions and a refined understanding of protective Ab responses to engineer novel antigens presenting epitopes with conformations relevant to eliciting or discovering protective humoral responses. For human immunodeficiency virus-1 (HIV-1), one model of protection is provided by broadly neutralizing Abs (bnAbs) against epitopes present in the closed prefusion trimeric conformation of HIV-1 envelope glycoprotein, such as the variable loops 1-2 (V1V2) apex. Here, computational design and directed evolution yielded a novel V1V2 sequence variant with potential utility for inclusion in an immunogen for eliciting bnAbs, or as an epitope probe for their detection. The computational design goal was to engineer a minimal single-chain antigen with three copies of the V1V2 loops to support maintenance of closed prefusion V1V2 trimeric conformation and presentation of bnAb epitopes. Via directed evolution of this computationally designed single-chain antigen, we isolated a V1V2 sequence variant that in monomeric form exhibited preferential recognition by quaternary-preferring and conformation-dependent mAbs. Structural context and transferability of this phenotype to V1V2 sequences from all strains of HIV-1 tested suggest a conformation-stabilizing effect. This example demonstrates the potential utility of computational design and directed evolution-based protein engineering strategies to develop minimal, conformation-stabilized epitope-specific antigens.

摘要

基于结构的抗原设计方法利用了抗体(Ab)与抗原相互作用的相关见解,以及对保护性Ab反应的深入理解,来设计新型抗原,这些抗原呈现出与引发或发现保护性体液反应相关构象的表位。对于人类免疫缺陷病毒1型(HIV-1),一种保护模型由针对HIV-1包膜糖蛋白封闭预融合三聚体构象中存在的表位的广泛中和抗体(bnAbs)提供,例如可变环1-2(V1V2)顶端。在此,通过计算设计和定向进化产生了一种新型V1V2序列变体,它有可能用于包含在免疫原中以引发bnAbs,或作为检测它们的表位探针。计算设计的目标是设计一种最小的单链抗原,其具有三个V1V2环拷贝,以支持维持封闭预融合V1V2三聚体构象并呈现bnAb表位。通过对这种通过计算设计的单链抗原进行定向进化,我们分离出一种V1V2序列变体,其单体形式表现出被优先识别四级结构且依赖构象的单克隆抗体的特性。这种表型的结构背景及其对所有测试的HIV-1毒株的V1V2序列的可转移性表明存在构象稳定作用。这个例子证明了基于计算设计和定向进化的蛋白质工程策略在开发最小的、构象稳定的表位特异性抗原方面的潜在效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/6885368a2df6/gzy010f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/788e157aab54/gzy010f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/21b9ef7e01e0/gzy010f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/b36e11bc9362/gzy010f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/237d262f59f9/gzy010f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/7f92f083111d/gzy010f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/6885368a2df6/gzy010f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/788e157aab54/gzy010f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/21b9ef7e01e0/gzy010f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/b36e11bc9362/gzy010f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/237d262f59f9/gzy010f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/7f92f083111d/gzy010f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93e/6030936/6885368a2df6/gzy010f06.jpg

相似文献

1
Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen.迈向HIV-1四级表位的构象保真度:最小化V1V2抗原的计算设计与定向进化
Protein Eng Des Sel. 2018 Apr 1;31(4):121-133. doi: 10.1093/protein/gzy010.
2
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.靶向HIV-1 gp120 V1V2的合理设计免疫原在兔体内诱导不同的构象特异性抗体反应。
J Virol. 2016 Nov 28;90(24):11007-11019. doi: 10.1128/JVI.01409-16. Print 2016 Dec 15.
3
Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.对HIV-1包膜V1V2结构域进行合理靶向突变以增强抗V1V2单克隆抗体的病毒中和作用
PLoS One. 2015 Oct 22;10(10):e0141233. doi: 10.1371/journal.pone.0141233. eCollection 2015.
4
Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.设计并鉴定一种缺乏 V1V2 环关键糖基的、天然样三聚体、种系靶向可溶性 HIV-1 Env。
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129733. doi: 10.1016/j.bbagen.2020.129733. Epub 2020 Sep 16.
5
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.一种三聚体HIV-1包膜糖蛋白120免疫原在兔和恒河猴中诱导出针对HIV-1的强效且广谱的抗V1V2环抗体。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01796-17. Print 2018 Mar 1.
6
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.靶向HIV-1 gp120 V2区域的合理设计疫苗可诱导集中的、跨亚型反应性的、具有生物学功能的抗体反应。
J Virol. 2016 Nov 28;90(24):10993-11006. doi: 10.1128/JVI.01403-16. Print 2016 Dec 15.
7
Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques.DNA 表达三聚体 HIV V1V2 引发可改变免疫优势 有利于恒河猴中 V2 特异性抗体的产生
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01193-20.
8
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.婴儿来源的 HIV-1 包膜糖蛋白中的一个罕见突变改变了二聚体间的稳定性,并影响了针对三聚体顶部的广谱中和抗体的敏感性。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00814-20.
9
Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.基于 CD4 和 PG16 结合态突变容忍性的 HIV-1 包膜构象工程。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.00219-19. Print 2019 Jun 1.
10
Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.构象 V2 特异性抗 HIV 人源单克隆抗体的表位作图揭示 V2 中的一个免疫优势位点。
PLoS One. 2013 Jul 29;8(7):e70859. doi: 10.1371/journal.pone.0070859. Print 2013.

引用本文的文献

1
Design of peptides with high affinity binding to a monoclonal antibody as a basis for immunotherapy.设计与单克隆抗体高亲和力结合的肽作为免疫治疗的基础。
Peptides. 2021 Nov;145:170628. doi: 10.1016/j.peptides.2021.170628. Epub 2021 Aug 16.
2
Diverse contributions of avidity to the broad neutralization of Dengue virus by antibodies targeting the E dimer epitope.针对 E 二聚体表位的抗体对登革病毒的广泛中和作用的亲和力的多样性贡献。
Virology. 2021 Jul;559:57-64. doi: 10.1016/j.virol.2021.03.013. Epub 2021 Mar 30.
3
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.

本文引用的文献

1
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.来自不同进化枝的HIV-1包膜糖蛋白可区分疫苗接种者的抗体反应和持久性。
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.01843-17. Print 2018 Apr 15.
2
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.用于评估抗原特异性抗体效应子谱的多重Fc阵列。
J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3.
3
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
通过降低构象灵活性的工程化 V1V2 免疫原诱导交叉反应性 HIV-1 特异性抗体应答。
Vaccine. 2020 Apr 16;38(18):3436-3446. doi: 10.1016/j.vaccine.2020.03.010. Epub 2020 Mar 17.
4
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers.HIV-1疫苗研究与自然感染中的V2特异性抗体:控制因素还是替代标志物
Vaccines (Basel). 2019 Aug 6;7(3):82. doi: 10.3390/vaccines7030082.
5
Protein ensembles link genotype to phenotype.蛋白质聚集体将基因型与表型联系起来。
PLoS Comput Biol. 2019 Jun 20;15(6):e1006648. doi: 10.1371/journal.pcbi.1006648. eCollection 2019 Jun.
靶向HIV-1 gp120 V1V2的合理设计免疫原在兔体内诱导不同的构象特异性抗体反应。
J Virol. 2016 Nov 28;90(24):11007-11019. doi: 10.1128/JVI.01409-16. Print 2016 Dec 15.
4
Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody.经改造以增强与广泛中和性PG9抗体结合能力的HIV-1糖蛋白120 V1/V2结构域片段。
Mol Immunol. 2016 Sep;77:14-25. doi: 10.1016/j.molimm.2016.07.003. Epub 2016 Jul 21.
5
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles.展示具有自组装纳米颗粒的类天然三聚体 HIV-1 抗原。
Nat Commun. 2016 Jun 28;7:12041. doi: 10.1038/ncomms12041.
6
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.逆向疫苗学2.0:人类免疫学指导疫苗抗原设计。
J Exp Med. 2016 Apr 4;213(4):469-81. doi: 10.1084/jem.20151960. Epub 2016 Mar 28.
7
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.HIV-1包膜蛋白V1V2区与广泛中和抗体的结构揭示了有助于疫苗设计的共性。
Nat Struct Mol Biol. 2016 Jan;23(1):81-90. doi: 10.1038/nsmb.3144. Epub 2015 Dec 21.
8
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.稳定的三聚体流感血凝素茎作为一种广泛保护性的免疫原。
Science. 2015 Sep 18;349(6254):1301-6. doi: 10.1126/science.aac7263. Epub 2015 Aug 24.
9
Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design.经工程改造的不依赖切割的HIV-1包膜三聚体,作为用于疫苗设计的可溶性天然刺突模拟物。
Cell Rep. 2015 Apr 28;11(4):539-50. doi: 10.1016/j.celrep.2015.03.047. Epub 2015 Apr 16.
10
Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.酵母展示的HIV-1 SOSIP gp140刺突蛋白的定向进化,以提高其表达水平及对构象抗体的亲和力。
PLoS One. 2015 Feb 17;10(2):e0117227. doi: 10.1371/journal.pone.0117227. eCollection 2015.